Welcome to LookChem.com Sign In|Join Free
  • or
Ethyl 2,3-dibromo-3-(3,4,5-trimethoxyphenyl)propionate is a complex organic chemical compound with the molecular formula C14H19Br2O5. It is a derivative of propionic acid, featuring a propionate group (a three-carbon carboxylic acid chain) with two bromine atoms attached to the second and third carbons, and a 3,4,5-trimethoxyphenyl group attached to the third carbon. The trimethoxyphenyl group consists of a benzene ring with three methoxy groups (-OCH3) attached to the 3rd, 4th, and 5th carbons. ethyl 2,3-dibromo-3-(3,4,5-trimethoxyphenyl)propionate is characterized by its unique structure and potential applications in various chemical and pharmaceutical industries, such as the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals. Due to its specific functional groups and structural features, it may exhibit unique chemical properties and reactivity, making it a valuable compound for research and development in the field of organic chemistry.

5729-22-6

Post Buying Request

5729-22-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5729-22-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5729-22-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,7,2 and 9 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 5729-22:
(6*5)+(5*7)+(4*2)+(3*9)+(2*2)+(1*2)=106
106 % 10 = 6
So 5729-22-6 is a valid CAS Registry Number.

5729-22-6Relevant academic research and scientific papers

Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer's disease agents

Miao, Yuhang,Sun, Jie,Wang, Xiaojing,Yang, Jie,Yun, Yinling

, (2020/01/03)

Alzheimer's disease (AD) is a progressive neurological degenerative disease that has complex pathogenesis. A variety of studies in humans indicate that several enzymes inhibitors can be useful in the treatment of AD, including acetylcholinesterase (AchE), butyrylcholinesterase (BuChE) and monoamine oxidase (MAO). Various substituted 4-arylcoumarin derivatives were synthesised, and their activity in vitro were investigated, including AChE/BuChE inhibitory activity, MAO inhibitory activity, and antioxidant activity. Most of the compounds were found to exhibit high inhibitory activity, and individual compounds have extremely excellent activities. Therefore 4-arylcoumarins provides an idea for drugs design for the development of therapeutic or preventive agents for AD.

Synthesis and biological evaluation of novel neoflavonoid derivatives as potential antidiabetic agents

Wang, Bing,Li, Na,Liu, Teng,Sun, Jie,Wang, Xiaojing

, p. 34448 - 34460 (2017/07/22)

Various substituted neoflavonoid derivatives were synthesized using sulfated montmorillonite K-10 as a catalyst. This method is environmental friendly, sustainable and economical, convenient in isolation and purification processes, with little byproducts, using earth-abundant catalysts and has relatively high yield. Those neoflavonoid derivatives were screened for antioxidant, a-glucosidase inhibitory, aldose reductase 2 (ALR2) inhibitory and advanced glycation end-product formation inhibitory effects. Most compounds exhibited significant antioxidant and advanced glycation end-product (AGE) formation inhibitory activities. It was interesting to note that out of thirty compounds, 8k and 8l were found to have greater ALR2 inhibitory activity than the standard drug quercetin. The pharmacological studies suggested neoflavonoid with adjacent 7,8-dihydroxy groups were more effective in inhibiting ALR2. Antidiabetic activity studies had shown that compounds 8l and 8m were equipotent to the standard drug glibenclamide in vivo. In summary, the target compound 8l provided a potential drug design concept for the development of therapeutic or prophylactic agents of diabetes and diabetes complications.

Studies on the Constituents of the Seeds of Hernandia ovigera L. VII. Syntheses of (+/-)-Hernolactone and (+/-)-Hernandin

Tanoguchi, Mariko,Kashima, Tatsuhiko,Saika, Hideyuki,Inoue, Taishi,Arimoto, Masao,Yamaguchi, Hideo

, p. 68 - 72 (2007/10/02)

Two new lignans, hernolactone (1) and hernandin (2), isolated from the seeds of Hernandia ovigera L. were synthesized in racemic forms.Firstly, (+/-)-1 was obtained by utilizing the conjugate addition reaction of 4 with butenolide followed by alkylation with trimethoxybenzyl bromide and subsequent removal of the protecting groups.Synthesis of 2 was pursued using the corresponding 4-phenyl-1,2-dihydronaphthalene lactone (18).The cleavage of the lactone moiety of 18 afforded an unsaturated hydroxy acid (22).Subsequent hydrogenation of 22 followed by acidification with concentrated hydrochloric acid gave isopicrohernandin (21), leaving the 2,3-trans, 3,4-cis hydroxy acid (23), which was lactonized by means of N,N-dicyclohexylcarbodiimide to afford (+/-)-2.Keywords: Hernandia ovigera; hernolactone; hernandin; lignan; dibenzylbutyrolactone lignan; phenyltetralin lignan; isopicrohernandin; Diels-Alder reaction

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5729-22-6